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Long noncoding RNAs (lncRNAs) modulate various
biological processes, but their role in host antiviral
responses is largely unknown. Here we identify a
lncRNA as a key regulator of antiviral innate immu-
nity. Following from the observation that a lncRNA
that we call negative regulator of antiviral response
(NRAV) was dramatically downregulated during
infection with several viruses, we ectopically ex-
pressed NRAV in human cells or transgenic mice
and found that it significantly promotes influenza A
virus (IAV) replication and virulence. Conversely,
silencing NRAV suppressed IAV replication and virus
production, suggesting that reduction of NRAV is
part of the host antiviral innate immune response to
virus infection. NRAV negatively regulates the initial
transcription of multiple critical interferon-stimulated
genes (ISGs), including IFITM3 andMxA, by affecting
histone modification of these genes. Our results pro-
vide evidence for a lncRNA inmodulating the antiviral
interferon response.
INTRODUCTION
Thousands of lncRNAs are pervasively transcribed in mamma-
lian cells. Accumulating data indicate that they are an important
class of regulatory RNAs in a variety of cellular processes
(Mercer et al., 2009). To serve the function of signaling, decoying,
scaffolding, or guiding, lncRNAs employ their motifs to interact
with other molecules (Guttman and Rinn, 2012; Wang and
Chang, 2011). Most recently, three lncRNAs (murine NeST,
human THRIL, and NEAT1) are shown to regulate the innate
immunity by modulating the transcription of IFN-g, TNF-a, and616 Cell Host & Microbe 16, 616–626, November 12, 2014 ª2014 ElsIL8, respectively (Cullen, 2013; Gomez et al., 2013; Imamura
et al., 2014; Li et al., 2014). In addition, mouse lincRNA-Cox2
plays a central role in control of the Pam3CSK4-induced inflam-
matory response (Carpenter et al., 2013). Whole transcriptome
studies have also demonstrated the differential expression of
lncRNAs in SARS coronavirus-infected mice (Peng et al., 2010)
and enterovirus 71-infected RD cells (Yin et al., 2013), suggest-
ing the functional involvement of lncRNAs in antiviral immunity.
Interestingly, several lncRNAs have been shown to modulate
viral infection. For example, 7SL and NEAT1 are evidenced to
interfere with the HIV-1 virion package and posttranscriptional
expression (Wang et al., 2007; Zhang et al., 2013). lncRNA VIN
can facilitate influenza A virus (IAV) propagation (Winterling
et al., 2014). Despite these progresses, the specific functions
of these lncRNAs in the host defense process remain incom-
pletely characterized.
IAV infection poses a significant threat to global health (Ma¨nz
et al., 2013), but themechanisms underlying IAV-host interaction
are still elusive. Host anti-IAV response is initiated by the recog-
nition of viral components by pathogen recognition receptors
(PRRs), such as retinoic acid-inducible gene I (RIG-I), melanoma
differentiation factor 5 (MDA5), and toll-like receptor 3 (TLR3).
Through the signaling cascade downstream the stimulated
receptors, transcription factors including IRF3/7 and NF-kB are
activated. Type I and III interferons (IFNs) are then rapidly
produced, which induce the synthesis of hundreds of antiviral
proteins encoded by IFN-stimulated genes (ISGs). Conse-
quently, the accumulation of ISG proteins in cytosol, including
the well-known IFN-induced protein with tetratricopeptide
repeats IFIT2, IFIT3 (Fensterl et al., 2012; Liu et al., 2011), IFN-
induced transmembrane protein 3 (IFITM3) (Everitt et al., 2012),
and myxovirus resistance 1 (human MxA or mouse Mx1) (Ma¨nz
et al., 2013), provides antiviral protection through multiple
mechanisms. Importantly, modulation of anti-IAV immunity
epigenetically has emerged to be a critical mechanism. After
the activation of transcription factors, a transcriptional regulation
cascade is triggered (Smale, 2012). The cascade includesevier Inc.
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controlled by a complex network. First of all, regulations of pro-
moter activity and chromatin structure are essential steps for the
transcription initiation. For example, the activation of the pro-
moters of immune genes ifit2, ifit3, and mx1 requires nucleo-
some remodeling through SWItch/Sucrose NonFermentable
(SWI/SNF) complexes and histone modifications (H3K4me3 or
H3K9/K14ac) (Ramirez-Carrozzi et al., 2009). IFN-g promoter is
reported to be upregulated by lncRNA NeST, which binds with
H3K4 methylase complex component WDR5 to alter histone
methylation levels (Gomez et al., 2013). In addition, the mRNA
maturation and stabilization are also critical posttranscriptional
regulation steps. Heterogeneous nuclear ribonucleoproteins
(hnRNPs) regulate gene transcription and subsequent modifica-
tion of the newly synthesized RNA (pre-mRNA) in nucleus.
Recent studies have shown that hnRNP L and hnRNP A/B are
associated with the induction of immunity genes TNF-a and
CCL5 through interaction with lncRNA THRIL and lincRNA-
Cox2, respectively (Carpenter et al., 2013; Li et al., 2014). These
data suggest that additional coregulators are required for tran-
scriptional activation/inhibition of innate immunity genes.
In this study, genome-wide profiling of lncRNA expression
identified a human lncRNA, designated NRAV, that played a crit-
ical role in anti-IAV infection. In vitro and in vivo data showed that
NRAV functioned as a negative regulator in the host antiviral
immunity by repression of ISG production through strict control
of the transcription rate. Furthermore, we found that NRAV regu-
lated the expression of MxA and IFITM3, likely through affecting
histone modification of their genes. These results reveal a layer
of the regulation of host innate defense during the IAV infection.
RESULTS
Human NRAV Is Identified as a lncRNA Controlling
Virus Infection
To investigate the roles of host lncRNAs in IAV infection,
genome-wide lncRNA microarrays were performed of human
alveolar epithelial cells (A549) infected with or without influenza
virus A/WSN/33 (H1N1) for 12 hr. A total of 494 upregulated
and 413 downregulated lncRNAs following the viral infection
were detected (fold change >2) and clustered (Figure 1A, left).
Nine lncRNAs were selected as candidates after an in silico
screen (see Supplemental Information available online) and
confirmation by RT-PCR (Figure 1A, right).
To identify the functional lncRNAs, viral activity screening was
performed (Figures S1A and S1B). lncRNA NRAV was found to
affect the virus replication most significantly, and thus it was
chosen for in-depth study. The human lncRNA gene nrav
(LOC100506668, uc001tyk, also named as dynll1-as1) is located
on chromosome 12q24.31, overlapping with the antisense
strand of dynein light chain coding gene dynll1 within intron 1
(Figure 1B). No protein-coding potential was found in NRAV by
analysis using ORF Finder (NCBI), coding potential calculator
(score is 0.743) (Figure S1C), and PhyloCSF (score is 3452)
(Lin et al., 2011). Using polysome analysis, we further observed
that NRAV displayed different distribution patterns in sucrose
gradient fractions as compared with control protein-coding
mRNA of GAPDH that locates in the same fractions as polysome,
demonstrating the noncoding potential of NRAV (Figures S1DCell Host &and S1E). Importantly, both qRT-PCR and northern blotting
confirmed that NRAV expression was markedly reduced in
IAV-infected A549 cells (Figures 1C and 1D). Northern blot anal-
ysis using a specific probe (793 nt) demonstrated that the major
form of human NRAV was the transcript of approximately 1,200
nt (Figure 1D). Consistently, determination of 50 and 30 ends of
NRAV by RACE studies revealed that NRAV transcript is exactly
1,176 nt and contains a polyadenylated (12 As) tail (Figures 1E
and S1F; Table S1).
Furthermore, we observed that NRAV was downregulated in a
virus dose- and infection time-dependent manner (Figure 1F).
Interestingly, NRAV was expressed in various human cell lines,
and its expression was dramatically reduced after IAV infection
in all examined cell lines susceptible to the infection, but not in
cell lines (HeLa, HepG2) less permissive to IAV replication
(Figure 1G). Surprisingly, NRAVwas also significantly downregu-
lated by infections of several other viruses, including a negative
ssRNA virus Sendai virus (SeV), a dsRNA virus Muscovy Duck
Reovirus (MDRV), and a DNA virus herpes simplex virus (HSV)
(Figures 1H and 1I). In contrast, NRAV levels were not affected
by pseudovirus transduction, LPS treatment, etoposide stimula-
tion, or serum withdrawal (Figures S1G–S1J). Together, these
experiments demonstrate that reduction of NRAV level is associ-
ated with viral infection.
In addition, we identified NRAV homolog-coding sequences in
monkey and mouse genomes through Blast (NCBI) in silico anal-
ysis. However, we only detected NRAV homolog transcript in
monkey Vero cells, but not in mouse cells by RT-PCR (Figures
S1K and S1L). These results suggest that the nrav gene may
be conserved but evolved to be differentially regulated.
Altering NRAV Expression Has Profound Effects
on IAV Replication in Human Cells
To further determine the functionality of NRAV in IAV infection,
we generated A549 and 293T cell lines stably expressing
whole length of the human NRAV or specific shRNAs targeting
NRAV using the retroviral vectors or shRNA-based lentivectors
(Figures 2A, S2A, and S2B). Although IAV infection reduced the
endogenous NRAV expression, it had no significant effects on
the ectopically expressed NRAV and could not diminish the dif-
ference of NRAV expression between sh-Luc control cells and
NRAV knockdown cells (Figure 2B). Strikingly, both the virus
growth kinetics measured by haemagglutination assay and the
virus titers determined by plaque-forming test showed that
forced expression of NRAV significantly promoted the viral
replication, while disruption of NRAV expression consistently
impaired the virus reproduction in A549 cells (Figures 2C–2E).
The sh-NRAV-1 cells with lower NRAV expression were used in
further studies. Similar results were obtained fromNRAV overex-
pression and knockdown in 293T cells (Figure S2C). The
increased virus titers in supernatant from NRAV-overexpressing
cells were further confirmed by western blotting using an anti-
body against the IAV hemagglutinin (HA) (Figures S2D and
S2E). Because IAV infection caused a marked decrease in
NRAV expression in A549 cells, we determined whether NRAV
levels in NRAV-knockdown cells were lower than those in the
control cells during IAV infection. Indeed, the knockdown cells
showed clearly low levels of NRAV compared with the controls
(Figure 2F). However, the DYNLL1 levels were not affected byMicrobe 16, 616–626, November 12, 2014 ª2014 Elsevier Inc. 617
Figure 1. Human NRAV Is Identified as a
lncRNA Involved in Virus Infection
(A) Microarray analysis revealed 494 upregulated
and 413 downregulated lncRNAs in IAV-infected
A549 cells compared to control (n = 3; fold
change > 2.0; p < 0.05) (left). Cells infected with
WSN were collected 12 hr postinfection (hpi). The
RNA quantitation is shown as centered and scaled
log2 data in heatmaps. The differential expressions
of 9 selected lncRNAs were confirmed by RT-PCR
(right). NRAV (uc001tyk.1) is indicated by red rect-
angle.
(B) Shown is a paradigm of the genomic location of
lncRNA gene nrav (purple) and the relationship with
gene dynll1 (light blue). The probe for NRAV used in
northern blot (NB) (red bar) and the primers for
DYNLL1 (blue bar) are indicated (not scaled).
(C and D) The downregulation of NRAV in infected
A549 cells was confirmed by qRT-PCR (C) (n = 3;
means ± SEM; *p < 0.05) and northern blot (D).
Arrow indicates the abundant form of NRAV.
(E) The 50 and 30 end sequences of NRAV in A549
determined by 50 and 30 RACE and NCBI se-
quences of BC065744 and BC053632 are shown.
(F) A549 cells were infected with WSN at indicated
mois for 12 hr or at an moi of 3 for indicated hours.
RT-PCR was performed to determine the NRAV
expression.
(G) The NRAV expression in indicated human cell
lines infected with/without WSN (moi = 3) for 12 hr
was examined by RT-PCR. The viral nucleoprotein
(NP) was examined by western blotting.
(H and I) The NRAV expression was detected in
cells infected with Sendai virus (SeV), Muscovy
duck reovirus (MDRV), or herpes simplex virus
(HSV) by RT-PCR (H) and qRT-PCR (I).
Shown are representative RT-PCR results from
three independent experiments. Data are shown as
means ± SEM (n = 3; *p < 0.05; **p < 0.01). See also
Figure S1 and Table S1.
Cell Host & Microbe
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likely through a cis-effect on DYNLL1 (Figures S2F and S2G).
These data suggest that lncRNA NRAV is involved in regulating
IAV replication, and downregulation of NRAV in infected cells
might be a host self-protection response to the virus infection,
which may be critical to viral clearance.618 Cell Host & Microbe 16, 616–626, November 12, 2014 ª2014 Elsevier Inc.Expression of Human NRAV
Significantly Increases IAV
Virulence in Transgenic Mice
Although we did not succeed in detecting
mouse lncRNA NRAV, mouse genome
contains the nrav homolog sequence. To
further define the role of NRAV in IAV
infection, we wished to establish a more
physiological model system. For this,
transgenic (TG) mice expressing human
NRAV were generated as previously
described (Wei et al., 2014). The trans-
genic founders with high NRAV expres-
sion in lung were selected (Figure 3A).
The TG mice and wild-type (WT) litter-mates were intranasally inoculated withWSN virus, and the influ-
ence of NRAV on the virulence and infection kinetics was
analyzed. As expected, the IAV showed a considerably higher
virulence in TG mice than that in WT mice. Under our experi-
mental condition, body weight loss of infected TG mice was
observed on day 4 postinfection (dpi) (Figure 3B). By 5–9 dpi,
Figure 2. Altering NRAV Expression Has Profound Effects on IAV
Replication in Human Cells
(A and B) The efficiency of NRAV overexpression and shRNA-based knock-
down was determined by RT-PCR (A) in uninfected A549 cells or by qRT-PCR
(B) in WSN infected A549 cells.
(C and D) IAV replication kinetics of NRAV-overexpressing (C) and NRAV
knockdown (D) A549 cells were examined by hemagglutinin (HA) assay (moi =
0.3). The virus titers in supernatants were measured at indicated time points.
(E) IAV replication was examined by plaque assay. Virus titers in supernatants
were measured at 16 hpi. Shown are representative results from infected
overexpression cells (moi = 0.3) and knockdown cells (moi = 1).
(F) The expression of NRAV in infected NRAV knockdown cells was analyzed at
indicated time (moi = 1) by qRT-PCR.
Cells expressing empty vector (EV) or luciferase shRNA (sh-Luc) were used as
controls. n = 3; means ± SEM. See also Figure S2.
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weight, and with an average loss of approximately 25% on
8 dpi. All infected TG mice died within 9 dpi (Figure 3C). Under
the same conditions, however, inoculatedWT littermates started
body weight loss on 5 dpi, with an average loss of approximately
8% on 8 dpi, and only approximately 40% of infected WT mice
succumbed within 9 dpi (Figure 3C). Approximately 60% in-
fected WT mice gained body weight gradually after 8 dpi and
finally survived.
To further evaluate the in vivo effect of NRAV on IAV pathogen-
esis, we compared the viral loads and pathologies of the infected
TG mice with WT littermates. Strikingly, the lung viral titer in TG
mice was significantly higher than that in WT mice (Figure 3D),
indicating more active replication of IAV in TG mice expressing
NRAV. Remarkably, pathologic examination by hematoxylin
and eosin (H&E) staining displayed more severe inflammation in
the lungs of infected TGmice than those of the WT controls (Fig-
ure 3E). Together, these observations reveal that expression of
lncRNANRAV renders TGmicemore susceptible to IAV infection.Cell Host &NRAV Negatively Regulates the Expression
of Several Critical ISGs
In an attempt to define the mechanism of NRAV affecting IAV
replication, we performed a cDNA microarray to profile the
cellular transcriptional response to NRAV overexpression in
A549 cells infected with WSN for 16 hr. The microarray data dis-
played 882 genes upregulated and 1,538 genes downregulated
(over 2-fold change, p < 0.05) in NRAV-overexpressing cells as
comparedwith the controls (Figure 4A, left). Many of the differen-
tially expressed genes were found to be associated with path-
ogen infection and viral reproduction through pathway analysis
and Gene Ontology (GO) analysis (Figures S3A and S3B). Sur-
prisingly, we identified 107 ISGs from differentially expressed
genes in NRAV-overexpressing cells, and strikingly, the enrich-
ment score of these ISGs was significantly high (21.3) using
the analysis with interferome (Rusinova et al., 2013) (Table S2).
Since ISGs are important antiviral effectors, we focused specif-
ically on the ISG genes for further studies. Importantly, mRNA
levels of some critical ISGs were significantly reduced in
NRAV-overexpressing cells, including IFIT2, IFIT3, IFITM3,
OASL, and MxA (Figure 4A, right). This finding was further
confirmed by qRT-PCR (Figure 4B). In contrast, the mRNA levels
of these ISGs were upregulated in NRAV knockdown cells
(Figure 4C). Furthermore, the expression of ISGs regulated by
NRAV was examined in IAV-infected NRAV TG mice and WT
littermates. Consistently, we found that the levels of these
ISGs in TG mice were significantly reduced as compared with
those in WT controls after infection with IAV (Figures 4D and
4E). These results reveal that NRAV functions as a negative regu-
lator of some ISGs during the IAV infection in vitro and in vivo.
Based on these data, we hypothesized that NRAV might
impair host antiviral response through downregulation of some
key ISGs, and if so, forced expression of these ISGs could
reverse the effects of NRAV overexpression on IAV pathogen-
esis. To this end, exogenous IFIT2, IFIT3, IFITM3, or MxA was
transiently expressed in the cell lines overexpressing NRAV or
empty vector (EV) (Figure S3C). Indeed, forced expression of
IFIT2, IFIT3, IFITM3, or MxA reversed the effect of NRAV on
the IAV replication despite existence of excessive NRAV,
whereas expression of control DDX3X, a component of TBK1-
dependent innate immune response, had no such a function
(Figures S3D and S3E). Because previous studies have shown
that MxA interacts with IAV protein NP to inhibit the viral tran-
scription (Ma¨nz et al., 2013), we tested whether NRAV knock-
down had any effects on IAV cRNA levels. Indeed, we found
that the cRNA levels were clearly low in NRAV-depleted cells
compared to the control at 8 hpi (Figure S3F), suggesting that
the increased MxA caused by NRAV downregulation may block
IAV transcription. However, altering NRAV expression has no
significant effect on viral entry at early stage of viral infection
(4 hr) (Figure S3G). These results suggest that lncRNA NRAV is
critically involved in regulation of innate immune response via
controlling the levels of several critical ISGs during the viral
infection.
NRAV Suppresses MxA Expression Induced
by Different Virus Infection and IFN Stimulation
Results presented above revealed thatMxA levels were themost
significantly affected by altering NRAV expression. To confirmMicrobe 16, 616–626, November 12, 2014 ª2014 Elsevier Inc. 619
Figure 3. Expression of Human NRAV Signif-
icantly Increases IAV Virulence in Transgenic
Mice
(A) The genotype (upper) and NRAV expression
(middle) of C57BL/6J TG mice were determined
by PCR of mouse tail DNA and RT-PCR of tissue
RNA. , WT littermates; +, TG mice; LG, lung; TH,
thymus. Photo of TG andWTmice is shown (lower).
(B and C) The influence of NRAV on the WSN viru-
lence and infection kinetics in mice were deter-
mined by body weight loss (B) and cumulative
survival curve (C). Five- to six-week-old TG andWT
mice were intranasally inoculated with 103 PFU of
WSN (8–10mice/group) or PBS (5 mice/group). The
dashed line in (B) indicates the endpoint of 25%
weight loss. Statistical significance in (C) was
determined by log rank test.
(D) The lung viral loads in infected TG and WT mice
as described in (B) were measured by plaque
forming assay on day 6 (13 mice/group).
(E) Representative light photomicrographs of the
mouse lung stained with HE on 6 dpi. The leukocyte
infiltration was more pronounced in the infected TG
mice in comparison with infected WT mice. Scale
bars, 20 mm.
Data were shown as means ± SEM. *p < 0.05,
**p < 0.01.
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protein. Similarly, we observed that MxA protein levels were
markedly affected by altered NRAV expression (Figure S4A).
Thus, MxA was selected for further studies. To further define
the functional involvement of NRAV in regulating MxA expres-
sion, we investigated the effect of NRAV on MxA expression
induced by different virus infections or stimulations. Interest-
ingly, overexpression of NRAV resulted in a significant decrease
in MxA expression in all cells infected with SeV for 12 hr or MDRV
or HSV for 24 hr (Figures 5A–5C and S4B–S4D). In addition, when
the cells were stimulated with bacterial lipopolysaccharides
(LPSs) for 3 hr, the MxA level in NRAV-overexpressing cells
was also significantly reduced as comparedwith the control cells
(Figures S4E and S4F).
Because virus-induced MxA expression is regulated by cyto-
kine-activated JAK/STAT1 signaling, we determined whether
NRAV had any effects on the activation of this signaling. To
test this possibility, phosphorylation of STAT1 was examined
by western blotting. Surprisingly, no significant difference in
the levels of p-STAT1 was observed between the infected
NRAV-overexpressing cells and the control cells (Figure 5D).
Our previous and current studies showed that A549 cells ectop-
ically expressing with or without NRAV are capable of producing
IFNs (Wei et al., 2014) (Figure S4G). Thus, we tested whether
NRAV had effects on total cytokine levels secreted by infected620 Cell Host & Microbe 16, 616–626, November 12, 2014 ª2014 Elsevier Inc.cells. Consistently, no significant differ-
ence in MxA levels was detected in the
fresh A549 cells stimulated with superna-
tants derived from either IAV-infected
NRAV-overexpressing cells or infected
control cells (Figures S4H and S4I, left).
A similar result was obtained from theNRAV-depleted cells and the control cells (Figure S4I, right).
Additionally, we found that the expression of MxA induced by
IFN-b or IL29 was significantly reduced in the NRAV-overex-
pressing cells compared with the control (Figures 5E, 5F, S4J,
and S4K). Together, these results reveal that NRAV negatively
regulates MxA expression in response to broad stimulations
without significantly altering total cytokine production and
JAK/STAT1 signaling.
NRAV Inhibits the Initial Transcription of MxA
and IFITM3, Likely through Regulating Histone
Modifications of the ISG Genes
Next, we investigated how NRAVmight regulate the ISG expres-
sion. To this end, we determined the cellular localization of NRAV
and found that although NRAV was localized both in the cyto-
plasm and nucleus, more NRAV was distributed in the nucleus
of A549 cell (Figures 6A and S5A). Thus, we presumed that
NRAV might be involved in transcriptional control of these
ISGs. The pre-mRNA level can represent the initial transcription
rate. Therefore, the primers to examine the pre-mRNA levels of
MxA (preMxA) and IFITM3 (preIFITM3) were designed as previ-
ously described (Zeisel et al., 2011) (Figure 6B). We observed
that the preMxA and preIFITM3 levels in infected NRAV-overex-
pressing cells were lower than those in control (p < 0.05), while
no bands were observed in no reverse transcriptase control
Figure 4. NRAV Negatively Regulates the
Expression of Several Critical ISGs
(A) cDNA microarray analysis displayed hundreds
of genes differentially expressed (n = 3, fold
change > 2.0, p < 0.05) in WSN infected NRAV-
overexpressing cells compared with control
(moi = 3; 16 hpi) (left). Significantly changed ISGs
and unchanged ISGs and IFN receptors are shown
(right). The RNA quantitation data are shown as
centered and scaled log2 data in heatmaps.
(B and C) The mRNA levels of ISGs in NRAV-
expressing and EV control cells (B) or NRAV
knockdown and sh-Luc control cells (C) infected
with or without WSN were determined by qRT-
PCR (n = 3).
(D and E) The mRNA levels of mIFIT2, mIFIT3,
mIFITM3, and mMx1 in infected TG or WT mouse
lungs were determined by RT-PCR (D) or by qRT-
PCR (E). In (D), 1 and 2 indicate two individuals.
Data are shown as means ± SEM. *p < 0.05,
**p < 0.01. See also Figure S3 and Table S2.
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transcription of MxA and IFITM3. Furthermore, we observed
that the promoter activity of both MxA and IFITM3 was signifi-
cantly reduced in NRAV-overexpressing cells compared with
control cells using a luciferase reporter assay (Figures S5B–
S5D). These observations suggest that NRAV may be involved
in negative regulation of promoter function of these ISGs.
Because lncRNAs were shown to silence gene transcription
through maintenance of DNA methylation (Mohammad et al.,
2012) andmxA contains a low CpG promoter (Ramirez-Carrozzi
et al., 2009), we determined whether NRAV affected the DNA
methylation of mxA gene. As shown in Figure S5E, treatment
of A549 cells with DNA methyltransferase inhibitor decitabine
(DAC) resulted in an increase of MxA mRNA level. However,Cell Host & Microbe 16, 616–626, Nexpression of MxA was still inhibited in
the presence of NRAV. In addition, we
examined the mRNA decay rate of MxA
in the infected cells treated with actino-
mycin D (ActD), since lncRNAs can acti-
vate mRNA decay through recruiting
STAU1 to mRNAs (Kretz et al., 2013). No
significant difference in the mRNA degra-
dation rates was detected between
NRAV-overexpressing cells and control
cells (Figures S5F and S5G). These data
indicate that NRAV may be not associ-
ated withMxADNAmethylation and post-
transcriptional regulation of MxA.
Histone modification at transcription
start sites is a crucial step for the regula-
tion of gene transcription, and previous
studies have proposed that lncRNAs
are involved in these processes (Wang
and Chang, 2011). Next, we investigated
the histone 3 lysine 4 trimethylation
(H3K4me3) as an active mark and histone
3 lysine 27 trimethylation (H3K27me3) as
a repression signal by performing chro-matin immunoprecipitation (ChIP). We found that the H3K4me3
enrichments at the mxA and ifitm3 transcription start sites
in NRAV-overexpressing cells were obviously impaired as
compared with those in control cells following IAV infection
(Figures 6F and S5H). In contrast, the H3K27me3 enrichment
at mxA gene locus in infected NRAV-overexpressing cells
exhibited remarkably higher than that in control cells, although
the H3K27me3 enrichment at ifitm3 remained unchanged
(Figures 6G and S5I). Consistently, NRAV knockdown resulted
in a significant increase in H3K4me3 enrichments and a signifi-
cant decrease in H3K27me3 enrichments at mxA and ifitm3
transcription start sites (Figures S5J and S5K). These data reveal
that NRAV may function to inhibit the ISG transcription by
affecting the histone modifications of these genes.ovember 12, 2014 ª2014 Elsevier Inc. 621
Figure 5. NRAV Suppresses MxA Expression Induced by Different
Virus Infection and IFN Stimulation
(A–C) The MxA mRNA levels in following NRAV cells and EV cells were
determined by qRT-PCR: SeV infected A549 cells (A), MDRV infected 293T
cells (B), and HSV infected A549 cells (C) (means ± SEM; n = 3).
(D) A549 cells overexpressing NRAV or control were infected with WSN for
indicated time. STAT1 and its Tyr701-phosphorylation were determined by
western blotting.
(E and F) The MxA mRNA levels in NRAV overexpressing cells and control
A549 cells stimulated by IFN-b (E) or IL29 (F) (50 ng/ml) for 3 hr were detected
by qRT-PCR (means ± SEM; n = 3). *p < 0.05, **p < 0.01. See also Figure S4.
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performed RNA pull-down by using biotinylated NRAV antisense
probes or scramble control probes. Interestingly, a specific
NRAV-bound protein in resting A549 cells was pulled down
and identified to be ZO-1-associated nucleic acid binding pro-
tein (ZONAB) by mass spectrometry (Figures 6H and S6A; Table
S3). This finding was further confirmed by RNA immunoprecipi-
tation (RIP) showing that the amount of NRAV precipitated with
anti-ZONAB Ab was dramatically higher than that of GAPDH
control (Figure S6B). We next determined the role of ZONAB in
MxA expression. The shRNA-based ZONAB knockdown was
performed and verified by qRT-PCR (Figure S6C). Interestingly,
the levels of MxA mRNA were significantly decreased after
silencing ZONAB in both infected and uninfected cells (Figure 6I).
When ZONAB was depleted in NRAV-overexpressing cells,
the MxA mRNA was decreased to a lower level (Figure 6J),
while NRAV was not affected by altered ZONAB expression
(Figure S6D, left). Consistently, the exogenous expression
of ZONAB in NRAV-overexpressing cells partially reversed
the NRAV-mediated suppression of MxA expression (Figures622 Cell Host & Microbe 16, 616–626, November 12, 2014 ª2014 ElsS6D–S6F). These results indicate that ZONAB is involved in
MxA transcription as a positive regulator.
The Spatial Structure of Functional Moieties
Was Essential for lncRNA NRAV Function
The diverse functions of lncRNAs are based on their propensity
to fold into thermodynamically stable secondary and higher-or-
der structures (Mercer and Mattick, 2013). To determine the
functional structures of lncRNA NRAV, we designed and con-
structed eight truncation and deletion mutants based on the pre-
dicted secondary structure of NRAV through three softwares,
RNAfold (Gruber et al., 2008), Centroidfold, and Genebee
(Figures 7A and 7B). As displayed, mutant A (mutA) lacks the
stem-loop arm A, while contains other stem-loop structures or
elements (arms C, D, and E) as compared with the intact NRAV
(Figure 7A). Ectopic expression of these mutants was deter-
mined by RT-PCR (Figure 7B, right). Interestingly, experiments
testing the effects of these mutants on virus replication demon-
strated that all examined structure moieties of NRAV except arm
D, which was a small arm of NRAV (nt 618–872), were required
for its role in controlling IAV replication (Figure 7C). Consistently,
the reduction of MxA mRNA level was detected only in cells
ectopically expressing WT NRAV or its mutD (Figure 7D). These
experiments demonstrate that RNA sequences of stem loops in
NRAV except nt 618–872 may form a spatial structure that is
essential for its function.
DISCUSSION
Although much emphasis has been placed on investigating host
protein factors in the activation of innate immune responses to
IAV infection, little is known about the role of lncRNAs in these
processes. lncRNA THRIL, NeST, NEAT, and lincRNA-Cox2
have been reported to regulate the expression of TNF-a,
IFN-g, IL8, and inflammatory response, respectively (Carpenter
et al., 2013; Gomez et al., 2013; Imamura et al., 2014; Li et al.,
2014). Here we report a human lncRNA named as NRAV, which
is expressed in various human cells, but significantly downregu-
lated during the IAV infection and infections with ssRNA virus
(SeV), dsRNA virus (MDRV), and DNA virus (HSV). Importantly,
we have revealed that overexpression of NRAV promotes the
IAV replication in vitro and in vivo by suppressing the expression
of several key ISGs, such as IFIT2, IFIT3, IFITM3, and MxA, very
likely through affecting the histone modifications of these ISG
genes. These findings establish that NRAV functions as an
important regulatory molecule via negatively regulating the
expression of some crucial antiviral proteins, which modulates
the host innate immune response against IAV infection and
maybe more broadly involved in other viral infections.
In uninfected cells, NRAV likely contributes to precise control
of the expression of these critical ISGs. When virus infection is
sensed, the reduction of NRAV would benefit the rapid accumu-
lation of the antiviral proteins to facilitate the clearance of virus.
Therefore, downregulation of NRAV may be initiated by host as
a self-protection response. This is coherent with the tight and
exquisite control of antiviral response that ensures rapid defense
against pathogens with minimal inflammatory damage. A
number of negative regulators of innate immunity have been
found, such as SOCS1 and SOCS3, which negatively regulateevier Inc.
Figure 6. NRAV Inhibits the Initial Transcrip-
tion of MxA and IFITM3 through Regulating
Histone Modifications of the ISG Genes
(A) The RNA levels of NRAV, cytoplasmic control
(GAPDHmRNA), and nuclear control (U6 RNA) were
assessed by qRT-PCR in cytoplasmic and nuclear
fractions from A549. The total RNA was used
as input control. Data are shown as % input
(means ± SEM; n = 3.)
(B) Paradigms of the pre-mRNA sturctures of MxA
(left) and IFITM3 (right) (not scaled). Introns (black
line) between two exons (black block) used for pre-
mRNA detection are indicated. Several pairs of
primers were used to detect two isoforms of pre-
MxA. Corresponding primers are shown as a pair of
arrows. Promoters are shown as bended arrows.
(C–E) The pre-mRNA levels of MxA (preMxA) and
IFITM3 (preIFITM3) in IAV infected NRAV-over-
expressing cells or EV control cells were deter-
mined by RT-PCR (C) and qRT-PCR (preMxA [D],
preIFITM3 [E]). Shown are representative data of
three independent experiments. Means ± SEM;
n = 3. *p < 0.05. RT, no reverse transcriptase in
reverse transcription (RT). RT, normal reaction. The
length of RT-PCR product is shown.
(F and G) ChIP analysis of H3K4me3 (F) and
H3K27me3 (G) levels at themxA and ifitm3 locus in
IAV-infected NRAV-overexpressing or control cells.
The relative amounts of mxA and ifitm3 DNA
immunoprecipitated by the anti-H3K4me3 or anti-
H3K27me3 antibody were normalized to that iso-
lated by the control IgG. The fold enrichment was
calculated as 2DDCt (mean ± SEM; n = 3).
(H) Silver staining of proteins pulled down by NRAV
antisense probes or scramble control probes from
A549 cell lysate. The specific NRAV-associated
band (arrow) was excised for mass spectrometry.
Shown are representative data from three inde-
pendent experiments.
(I) MxA mRNA levels in ZONAB-depleted A549 cells
infected with or without WSN (moi = 1, 12 hpi) were
measured by qRT-PCR and normalized to that of
uninfected control cells transfected with vector
sh-Luc.
(J) Experiments were performed as described in (I).
MxA mRNA levels in ZONAB-depleted NRAV-
overexpressing A549 cells were measured by qRT-
PCR.
Data are shown as means ± SEM; n = 3. *p < 0.05,
**p < 0.01. See also Figures S5–S7 and Table S3.
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Role of lncRNA NRAV in Antiviral ResponseIFN-activated JAK-STAT signaling to control the ISG transcrip-
tional response to IFN stimulation (Akhtar and Benveniste,
2011). LincRNA-Cox2 also mediates the repression of some
immune genes (Carpenter et al., 2013). Although the mechanism
underlying downregulation of NRAV by viral infection remains
elusive, the expression of NRAV is likely controlled by particular
pathways activated upon sensing the viral infection. Indeed, we
found that the NRAV downregulation was induced only by viral
RNA which is produced during virus replication (Figures S7A–
S7E) and newly synthesized protein(s) (Figure S7F). However,
these proteins might include neither virus-induced cytokines
nor IFNAR1 (Figures S7G–S7J). We observed that reduction of
NRAV was not caused by increase in RNA decay (Figure S7K),Cell Host &indicating that this protein(s) might be relevent with the transcrip-
tional regulation of NRAV. CpG islands and some transcription
factor binding sites on the upstream of nrav were predicted
(Figure S7L). Interestingly, DNA methyltransferase might partici-
pate in the regulation of NRAV (Figures S7M–S7P). These find-
ings suggest that virus infection might induce the transcription
inhibition of nrav through epigenetic modification.
We identified that NRAV critically regulated several key anti-
viral effectors in innate immunity. Strikingly, the transcriptional
regulations of these genes are distinct, andmultiple mechanisms
are involved. For example, MxA/Mx1 is regulated through
strictly IFN-dependent pathway, while IFIT2 and IFIT3 are
through both IFN-dependent and IFN-independent pathwaysMicrobe 16, 616–626, November 12, 2014 ª2014 Elsevier Inc. 623
Figure 7. The Spatial Structure of Func-
tional Moieties Was Essential for lncRNA
NRAV Activity
(A) Secondary structure predictions of NRAV and
mutations were performed through three soft-
wares (RNAfold, Certroidfold, and Genebee). The
mutation locations were labeled by circle or short
bar.
(B) Schematic diagram of truncation and deletion
mutations of NRAV is shown (left). The stable
exogenous expression of NRAV or its mutants in
A549 cells was determined by RT-PCR (right).
(C) A549 cells expressing NRAV or its mutants
were infected with IAV, and the virus titers in
culture supernatants were determined through
plaque-forming assay (n = 3; means ± SEM;
**p < 0.01).
(D) The MxA mRNA levels in A549 cells in (C) were
detected by RT-PCR. Shown are representative
results from three independent experiments.
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Role of lncRNA NRAV in Antiviral Response(Lazear et al., 2013). Interestingly, these NRAV-modulated ISGs
have recently been reported belonging to a subset of ISGs which
are regulated by an IKKi-associated specific signal pathway (Ng
et al., 2011; Tenoever et al., 2007). In this study, we found that the
initial transcription rates of MxA and IFITM3 were reduced and
the histone modifications (active mark H3K4me3 and repressive
mark H3K27me3) were altered by NRAV. Several lncRNAs have
been reported to regulate chromatin remodeling on specific
gene location through directly binding with hnRNPs (Carpenter
et al., 2013; Li et al., 2014). Although we have excluded the pos-
sibility that NRAV functions through regulating IFN-JAK/STAT1
pathway, the molecular mechanism by which NRAV regulates
the initial transcription and histone modifications remains un-
known. On the other hand, NRAV was shown to interfere with
the MxA and IFITM3 promoter activity in a luciferase reporter
system. These data suggest that there might exist multiple
mechanisms underlying NRAV-mediated regulation of ISG
transcription.
It has been thought that lncRNAs usually interact with other
molecules to exert regulatory activities. In this study, ZONAB
was identified as a NRAV-associated protein involved in MxA
transcription regulation. ZONAB is a multifunctional protein624 Cell Host & Microbe 16, 616–626, November 12, 2014 ª2014 Elsevier Inc.that regulates transcription of cyclin D1
and PCNA as an important transcription
factor and posttranscriptionally regulates
other protein and mRNA levels in cyto-
plasm (Lima et al., 2010; Nie et al.,
2012). Although it is unclear whether
ZONAB functions as a transcription
factor of ISG expression, we found a
ZONAB binding sequence (invert CCAAT)
at219 to –215 of MxA transcription start
region (Dolfini and Mantovani, 2013),
suggesting the potential involvement of
ZONAB in initial transcription of MxA.
Additionally, as a transcription factor
ZONAB might also be involved in histone
modifications and nucleosome packing(Rothenberg, 2014). It has been thought that ZONAB can upre-
gulate several chromatin remodeling components (histone H4
and HMG-I) and MYC that recruits core histone-modifying
enzymes to DNA (Sourisseau et al., 2006). Further experiments
are needed in the future to address how ZONAB interacts with
NRAV to regulate ISG expression.
Human NRAV is an intronic antisense lncRNA of dynein light-
chain gene dynll1. Although Dynein is shown to be recruited by
many viruses to facilitate their replication and enhance their
spread, and direct interaction of Dynll with virions is identified
(Merino-Gracia et al., 2011), we did not observe significant
change in the Dynll1 levels after altering the NRAV expression
(GEO accession number GSE48874; Figures S2F and S2G). Of
interest is that hundreds of genes differentially expressed in
NRAV-overexpressing cells and the pathway and GO analysis
indicated that many are associated with pathogen infection
and viral reproduction. In addition, the expression of NRAV in
different types of human cells also indicates its broad functions.
The expression of human NRAV in multiple tissues of TG mice
including lung, thymus, and bone marrow might be important
for the IAV pathogenesis. Therefore, the role of NRAV may be
not limited to the modulation of ISGs. Moreover, the decline of
Cell Host & Microbe
Role of lncRNA NRAV in Antiviral ResponseNRAV level can also be induced by other RNA/DNA virus infec-
tions. Hence, we surmise that NRAV-related cellular response
may be a universal defense against virus infection. The exact
relationship between NRAV distribution in different tissues and
its antiviral activities needs to be determined.
EXPERIMENTAL PROCEDURES
Microarray and Data Analysis
The lncRNA cDNA microarray was from Arraystar (Arraystar, Rockville, MD).
The cDNA microarray was performed using Human 12x135K gene expression
microarray (Roche NimbleGen, Madison, WI). Total RNAs from three indepen-
dent groups of WSN-infected A549 cells or control cells were prepared using
Trizol reagent (Invitrogen, Carlsbad, CA). cDNA synthesis, labeling, hybridiza-
tion, and data analysis were carried out as previously described (Guo et al.,
2014) (see Supplemental Information).
Cells, Viruses, Antibodies, and Plasmids
Cells, viruses, and antibodieswere described in the Supplemental Information.
For plasmid construction, human IFIT2, IFIT3, IFITM3, MxA, and DDX3X were
subcloned into the pcDNA3.1 and pCMV5a vectors. shRNA-based knock-
down plasmids were generated with a pSIH-H1-GFP lentiviral vector express-
ing shRNA.
Viral Infection and Virus Titers Assay
A549 cells were infected with IAV WSN, Sendai virus (SeV), or herpes simplex
virus (HSV), and 293T cells were infected with Muscovy duck reovirus (MDRV).
Virus titers in supernatants were determined (see Supplemental Information).
50 and 30 RACE
The 50 and 30 RACE analyses were performed using the SMARTer RACE cDNA
amplification Kit (Clontech) as per the manufacturer’s instructions. RACE
PCR products were cloned into pZeroBack (Tiangen, Beijing, China) and
sequenced.
Transgenic Mice and Virus Challenge
The mouse experimental design and protocols used in this study were
approved by the Research Ethics Committee of Institute of Microbiology,
Chinese Academy of Sciences (permit number PZIMCAS2012001). The
studies of mice were performed in strict accordance with the Regulation of
Institutional Research Ethics Committee of Institute of Microbiology. The
NRAV transgenic C57BL/6 mice were created as previously described
(Wang et al., 2014; Wei et al., 2014). Mice were inoculated intranasally with
WSN. Mouse lungs were collected for lung viral loads assay and H&E staining
(see Supplemental Information).
RNA Pull-Down Assay, RNA Immunoprecipitation,
and Chromatin Immunoprecipitation
Uninfected A549 cell lysates were used for RNA pull-down assay and RIP, and
IAV-infected A549 cells were subjected to ChIP assays using the Magna ChIP
A/G chromatin immunoprecipitation kit (Millipore) following themanufacturer’s
instruction as described in Supplemental Information.
Generation of Stable Cell Lines and Cell Stimulation
The stable NRAV-overexpressing cells and A549 cell lines stably expressing
specific ISGs were generated with a retroviral expression system by infecting
the cells with retroviruses encoding these genes. Recombinant human IFN-b
and IL29were purchased from PeproTech (Rocky Hill, NJ). For stimulation, un-
less indicated, cells were incubated for 2–3 hr with the recombinant cytokines
or peptides (see Supplemental Information).
Western Blotting and Northern Blotting
For western blotting, cell lysates were separated by SDS-polyacrylamide gel
electrophoresis, transferred onto a nitrocellulose membrane, and probed
with indicated antibodies as described previously (Wei et al., 2014). For north-
ern blotting, total RNA of A549 cell was isolated using Trizol reagent. Probe is a
DNA fragment of NRAV (793 bp, 358–1,150), which was radiolabeled by usingCell Host &Prime-a-Gene Labeling System (Promega). The assay was performed by using
Northernmax-gly kit (Invitrogen) and autoradiography.
Statistical Analysis
Comparison between groups was made using Student’s t test. Data represent
the mean ± SEM. Differences were considered statistically significant with
p < 0.05.
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